Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.07.037Source: DataRank Database

Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma is a research paper published in Journal of Allergy and Clinical Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: closedTopics (25)IDs (PubMed)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Njira Lugogo ORCID,Mario Castro ORCID,Alberto Papi ORCID,Arnaud Bourdin ORCID,Michael E. Wechsler ORCID

Live enrichment

PubMed:41242639

Regeneron Pharmaceuticals Inc

Sanofi US

closedLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

publisherhttps://api.elsevier.com/content/article/PII:S0091674925011273?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674925011273?httpAccept=text/plain

MeSH Terms

EosinophilsHumansAsthmaAnti-Asthmatic AgentsLeukocyte CountTreatment OutcomeSeverity of Illness IndexAdolescentAdultAgedMiddle AgedFemaleMaleYoung AdultAntibodies, Monoclonal, Humanized

Keywords

SafetyAsthmaBiomarkersLung functiontype 2efficacyExacerbationsFenoBlood Eosinophil CountDupilumab

Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma

FAIR Checklist

Authors (13)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)